The first two years of human life harbor one of the most consequential microbial ecosystems a person will ever carry, and a new international study suggests that this early period may also be a decisive window in the making of antimicrobial resistance. Analyzing fecal metagenomes from infants and young children aged zero to 24 months across six countries on two continents, researchers report that the gut resistome—the full collection of antibiotic resistance genes carried by gut microbes—is already rich, structured, and geographically distinctive long before children are old enough to have accumulated extensive personal antibiotic histories. The work, published in BMC Genomics, offers one of the clearest pictures yet of how resistance genes are assembled in the earliest stages of life, and it challenges a common assumption that antibiotic exposure alone writes the resistome’s script.
Led by Okugbe Ebiotubo Ohore and Guojing Yang of Hainan Medical University in China, with collaborators spanning institutions in China and the United Kingdom, the team examined metagenomic data from children in the United States, Norway, Spain, the United Kingdom, Denmark, and Nicaragua. Rather than focusing on a single clinical cohort, the researchers deliberately spanned a range of geographic, economic, and dietary contexts, allowing them to disentangle the relative contributions of antibiotics, geography, age, and feeding practices to the architecture of the early-life resistome. Their central question was deceptively simple: what actually drives the acquisition and organization of resistance genes in the infant gut?
The answer, at least in part, is more complicated than antibiotics alone. One of the study’s most striking findings concerns what happens when infants and young children are exposed to antibiotics. Contrary to the expectation that antibiotic pressure would uniformly enrich resistance genes—a kind of evolutionary arms race captured in real time—the researchers found that early-life antibiotic exposure was associated with a pronounced restructuring of the entire gut microbial community. Instead of a targeted expansion of resistance genes, they observed a decrease in overall microbial abundance and a corresponding drop in resistome abundance. In other words, antibiotics did not so much arm the infant gut with more resistance genes as they reshuffled and thinned the ecological landscape in which those genes reside.
This distinction matters because the ecology of the gut governs how resistance genes persist and spread. Antibiotic treatment disrupts microbial populations, and in the disturbed aftermath, the composition of surviving species—the organisms that happen to carry resistance determinants—determines what the post-treatment resistome looks like. The study’s findings suggest that early infancy, when the gut microbiome is still assembling itself from birth onward, is developmentally sensitive to this kind of perturbation. A course of antibiotics during this period does not simply add resistance genes; it can reset the trajectory of which organisms dominate and, by extension, which resistance genes are represented in the community.
At the same time, the study is careful not to dismiss the role of antibiotics entirely, nor to portray the infant resistome as purely a byproduct of drug exposure. A substantial fraction of resistance genes, the authors conclude, appears to be structured by early-life ecological and dietary factors rather than by antibiotic pressure. Geography, feeding practices, and age all emerged as significant determinants of resistome diversity and structure. Children in different countries carried measurably different repertoires of resistance genes, pointing to the influence of local environmental reservoirs, maternal transmission, healthcare practices, diet, and possibly sanitation infrastructure. Breastfeeding versus formula feeding, a well-established driver of early gut microbiome composition, also left its mark on the resistance gene landscape.
The taxonomic and functional composition of the early-life resistome follows a discernible hierarchy. Across the six countries, multidrug resistance genes were the most abundant class, and many of these operated through efflux pumps—molecular machinery embedded in bacterial membranes that actively expel a broad range of compounds, including multiple antibiotic classes simultaneously. Efflux-mediated multidrug resistance is particularly concerning from a clinical standpoint because a single mechanism can confer reduced susceptibility to structurally unrelated drugs, limiting the usefulness of several treatment options at once. Following multidrug resistance genes in abundance were those conferring resistance to peptide antibiotics and glycopeptides, with substantial additional contributions from genes conferring resistance to tetracycline, macrolide, and fluoroquinolone classes—three of the most widely used antibiotic families in both human medicine and agriculture.
The prominence of tetracycline and macrolide resistance genes in infants who may never have received those specific drugs is telling. It points to the likelihood that resistance determinants arrive in the infant gut through routes other than direct antibiotic selection: vertical transmission from the mother during birth, horizontal gene transfer from other gut organisms, acquisition from household members and pets, or ingestion of resistant organisms present in food, water, or the surrounding environment. In this view, the infant gut is less a blank slate being written on by antibiotics and more a developing ecosystem into which resistance genes are continuously seeded from multiple reservoirs, with antibiotics acting as one—important but not exclusive—force that shapes which seeds take root.
The study’s geographical comparisons carry particular weight in an era of growing recognition that antimicrobial resistance is a global problem with strongly local dynamics. Countries differ not only in antibiotic prescribing practices but in sanitation, water quality, agricultural antibiotic use, and the microbial composition of the environments children inhabit. Nicaragua, for example, represents a setting with different patterns of infectious disease burden and antibiotic availability than Denmark or Norway, and the resistome differences the researchers observed likely reflect those broader ecological realities. Understanding these geographic patterns in early life is crucial because resistance trajectories established in the first two years may persist or cascade into later childhood and adulthood, shaping an individual’s long-term risk of carrying resistant organisms and, by extension, their susceptibility to difficult-to-treat infections.
The developmental dimension of the findings is equally important. The first 24 months of life represent a period of rapid microbiome assembly, during which the gut transitions from a relatively sparse community at birth to a complex, adult-like ecosystem. This is a period of extraordinary microbial turnover, and it is also when the immune system is learning to distinguish friend from foe among gut bacteria. The study’s authors describe infancy as a critical window during which resistome composition is shaped by multiple non-exclusive forces—antibiotic exposure, geography, diet, age, and the complex ecological interactions among gut organisms. Because the microbiome is so plastic during this period, interventions aimed at reducing resistance gene burden or preventing the establishment of dangerous resistance determinants may be most effective if they target this early window rather than later life, when the microbiome is more stable and resistant to change.
For public health, the implications are twofold. On one hand, the findings reinforce the importance of judicious antibiotic use in infants and young children, not necessarily because antibiotics directly flood the gut with resistance genes, but because they perturb a fragile developing ecosystem in ways that can favor the persistence of resistant organisms. On the other hand, the study suggests that antibiotic stewardship alone will not be sufficient to reduce the early-life resistome, since a large share of resistance genes appears to arrive through routes unrelated to a child’s own antibiotic history. Addressing these routes will require attention to maternal health and vertical transmission, food safety, water quality, and household hygiene—domains that extend well beyond the clinic.
The research also contributes methodologically to the growing field of metagenomic resistome studies. By analyzing shotgun metagenomic data from multiple countries with a common analytical framework, the study offers a more standardized picture of early-life resistance gene profiles than previous single-cohort efforts. The multi-country design helps to distinguish universal features of the infant resistome—such as the dominance of multidrug efflux genes—from geographically variable ones, providing a template for future studies seeking to track resistance from infancy into later life. Longitudinal follow-up of the same children over time would be a natural next step, allowing researchers to determine whether early resistome patterns actually predict antibiotic resistance outcomes years later, or whether the early-life resistome is largely overwritten as children grow and their environments change.
What emerges from this study is a portrait of the infant gut resistome as a dynamic, ecologically structured community feature rather than a simple reflection of antibiotic pressure. Multidrug resistance genes, efflux pumps, tetracycline and macrolide determinants, and glycopeptide resistance are all present and measurable in the guts of children who are barely old enough to walk, assembled through a combination of inheritance, environmental exposure, diet, and—when it occurs—antibiotic perturbation. The study does not diminish the importance of antibiotic stewardship; rather, it situates antibiotics as one factor among several in a complex developmental process. In doing so, it reframes the origins of antimicrobial resistance not as a problem that begins with the first prescription, but as one that begins much earlier, in the first months of life, shaped by forces that span from the maternal microbiome to the sanitation systems of entire nations. Understanding those forces, the authors argue, is essential if the trajectory of antimicrobial resistance is to be altered at its source—before it becomes entrenched in the gut and far harder to reverse.
Subject of Research: Gut resistome development in infants and young children aged 0–24 months, focusing on geographical variation and the effects of antibiotic exposure on resistance gene profiles
Subject of Research: Biology
Article Title: Geographical variation and antibiotic exposure-associated perturbation of the early-life children’s gut resistome
Article References: Ohore, O. E., Zhou, S., Zhang, J., Odinga, E. S., Zhang, J., Kpokiri, E. E., Tang, T., Zhao, X.-L., Gu, J.-D., & Yang, G. (2026). Geographical variation and antibiotic exposure-associated perturbation of the early-life children’s gut resistome. BMC Genomics. https://doi.org/10.1186/s12864-026-13319-0
Image Credits: AI Generated
DOI: 10.1186/s12864-026-13319-0
Keywords: antimicrobial resistance, gut microbiome, resistome, infants, young children, antibiotic exposure, metagenomics, multidrug resistance, efflux pumps, geographical variation, feeding practices, early-life development
Cite Scienmag News
APA
MLA
Chicago
Morgan Morrow. (September 8, 2026). Antibiotic exposure and geography shape young children’s gut resistance genes. Scienmag. https://scienmag.com/antibiotic-exposure-and-geography-shape-young-childrens-gut-resistance-genes/
Morgan Morrow. “Antibiotic exposure and geography shape young children’s gut resistance genes.” Scienmag, 8 September 2026, https://scienmag.com/antibiotic-exposure-and-geography-shape-young-childrens-gut-resistance-genes/. Accessed 8 September 2026.
Morgan Morrow. “Antibiotic exposure and geography shape young children’s gut resistance genes.” Scienmag. September 8, 2026. https://scienmag.com/antibiotic-exposure-and-geography-shape-young-childrens-gut-resistance-genes/
Copy citation
Download RIS
Tags: antimicrobial resistance developmentantimicrobial resistance in early childhoodChild gut microbiomecross-country comparison of microbial resistanceearly childhood microbial ecologyearly childhood microbiotaearly-life antibiotic exposureearly-life resistome diversityfecal metagenomics in infantsgeographic influence on antibiotic resistancegeographic influence on antibiotic resistance genesglobal patterns of antibiotic resistance gene transmissionglobal patterns of antibiotic resistance genesimpact of antibiotic exposure on infant gut bacteriaimpact of diet and environment on resistance genesinfant gut microbiome developmentinfant gut resistomeinfluence of diet and environment on resistomeinternational gut microbiome studyinternational study of pediatric antimicrobial resistancemetagenomic analysis of children’s gutmicrobial ecosystem in first two years of lifepediatric microbial ecosystemsresistome assembly in infants
